摘要
目的 :探讨小儿清热宁联合小儿速效感冒灵治疗小儿急性上呼吸道感染的临床疗效。方法 :2 0 6例符合急性上呼吸道感染诊断标准的患儿 ,随机分为联合治疗组和泰诺酚麻美敏组。联合治疗组 10 5例用小儿清热宁配合小儿速效感冒灵口服 ,泰诺酚麻美敏组 10 1例用泰诺酚麻美敏口服溶液 ,两组治疗时间均为 3d。结果 :联合治疗组临床疗效(94 .3% )较泰诺酚麻美敏组 (78.3% )明显。 3d内热退稳定并不回升 ,联合治疗组 (97.1% )明显优于泰诺酚麻美敏组 (63.3% ) (P <0 .0 1)。结论 :小儿清热宁联合小儿速效感冒灵治疗小儿急性上呼吸道感染经济实惠 ,临床疗效满意。
AIM: To study the efficacy of Xiaoer qingre ning (XQN) combined with Xiaoer shuxiao ganmao ling (XSGL) in the treatment of children acute respiratory infection (AURI). METHODS: 206 cases of AURI were randomly divided into combined group (treating group) and tylenol group. 105 cases in combined group were given XQN orally combined with XSGL, and 101 cases in tylend group were given children tylenol. The treatment of both groups lasted 3 days. RESULTS: The clinical effect in combined group ( 94.3 %) was more than that of tylenol group ( 78.3 %). CONCLUSION: XQN combined with XSGL is both economical and satisfactory in the treatment of children AURI.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2003年第2期201-203,共3页
Chinese Journal of Clinical Pharmacology and Therapeutics